Concord Biotech to Attend UBS Non-Deal Roadshow in Singapore
Concord Biotech Ltd 路 Intimation 路 28 Oct 2026, 8:37 pm
Concord Biotech to Attend UBS Non-Deal Roadshow in Singapore Concord Biotech Limited announced that company officials will participate in-person at a Non-Deal Roadshow organized by UBS in Singapore on 3rd and 4th Nov'26. Discussions with analysts and institutional investors will focus exclusively on publicly available information, with no unpublished price-sensitive information being shared.
Original exchange filing (PDF)
More announcements from Concord Biotech Ltd
- Intimation of allotment of Bonus equity Shares 路 05 Nov 2026
- Transcript of Q2 - FY27 Earnings call held on October 28, 2026 路 03 Nov 2026
- Earning Call Recording- For the Second Quarter and half year ended on September 30, 2026 路 29 Oct 2026
- Investor''s presentation on unaudited standalone and consolidated financial results for the second quarter and half year ended on September 30, 2026 路 28 Oct 2026
- The Board of Directors at its meeting held on October 27, 2026 has fixed Wednesday, November 04, 2026 as record date for issuance of Bonus equity shares in the ratio of 1:1. 路 28 Oct 2026
- Unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended on September 30, 2026. 路 28 Oct 2026
- Concord Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 28 Oct 2026
- The Board of Directors of the Company, at its meeting held today i.e. Tuesday, October 27, 2026, has inter-alia considered and approved the Un-audited financial results for the quarter .... 路 28 Oct 2026
